SCHEMBL25197896

SCHEMBL25197896

c1ccc(CN2CCCC3(CC2)OC[C@@H](c2ccccc2)O3)cc1

nearest known ligand 0.64

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 7/20 0.64
TMEM97 Q5BJF2 3/20 0.64
HTR1A P08908 2/20 0.47
ADRA1D P25100 1/20 0.47
ADRA1A P35348 1/20 0.47
ADRA1B P35368 1/20 0.47
CYP3A4 P08684 1/20 0.43
HSD17B10 Q99714 1/20 0.43
LTA4H P09960 5/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
GRIN2D O15399 1/20 0.42
GRIN3B O60391 1/20 0.42
DRD2 P14416 1/20 0.42
GRIN1 Q05586 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
GRIN3A Q8TCU5 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24358373 0.78 SIGMAR1 (0.61) SIGMAR1TMEM97CYP3A4HSD17B10MEN1
SCHEMBL10120597 0.75 SIGMAR1 (0.56) SIGMAR1TMEM97CYP3A4HSD17B10MEN1
Iodide SCHEMBL30361728 0.75 TMEM97 (0.37) SIGMAR1TMEM97HTR1AADRA1DADRA1A
Iodide SCHEMBL25194148 0.75 TMEM97 (0.37) SIGMAR1TMEM97HTR1AADRA1DADRA1A
SCHEMBL14636163 0.72 ALDH1A1 (0.45) SIGMAR1TMEM97HTR1AADRA1DADRA1A
SCHEMBL11686136 0.72 SIGMAR1 (0.68) SIGMAR1TMEM97CYP3A4HSD17B10MEN1
SCHEMBL25190079 0.70 TACR1 (0.38) SIGMAR1TMEM97HTR1AADRA1DADRA1A
SCHEMBL30361752 0.70 TACR1 (0.38) SIGMAR1TMEM97HTR1AADRA1DADRA1A
Hydrochloric Acid SCHEMBL11689691 0.70 SIGMAR1 (0.66) SIGMAR1TMEM97CYP3A4HSD17B10MEN1
SCHEMBL14637316 0.69 TSHR (0.42) SIGMAR1TMEM97HTR1AADRA1DADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260138985-A1 Azepino-Indoles for the Treatment of Neurological and Psychiatric Disorders TERRAN BIOSCIENCES INC (US) 2026-05-21 US disclosed
US-20230159544-A1 AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
US-20230159544-A1 AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
US-20230159544-A1 AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS TERRAN BIOSCIENCES INC (US) 2023-05-25 US disclosed
WO-2023077125-A2 AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS TERRAN BIOSCIENCES, INC. (US) 2023-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260138985-A1 Azepino-Indoles for the Treatment of Neurological and Psychiatric Disorders TPH2, TPH1, HTR1D SIGMAR1 1075/4885TMEM97 1336/4885HTR1A 6/4885
US-20230159544-A1 AZEPINO-INDOLES FOR THE TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS TPH2, TPH1, SLC18A2 SIGMAR1 1729/4885TMEM97 3174/4885HTR1A 16/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.